Literature DB >> 31904114

Lifestyle factors and risk of myeloproliferative neoplasms in the NIH-AARP diet and health study.

Nikolai A Podoltsev1, Xiaoyi Wang2, Rong Wang2, Jonathan N Hofmann3, Linda M Liao3, Amer M Zeidan1, Ruben Mesa4, Xiaomei Ma2.   

Abstract

The etiology of Philadelphia chromosome-negative myeloproliferative neoplasms (MPN) is largely unknown. We assessed potential associations between lifestyle factors and MPN risk in the NIH-AARP Diet and Health Study. In this prospective cohort with 463,049 participants aged 50-71 years at baseline (1995-1996) and a median follow-up of 15.5 years, we identified 490 MPN cases, including 190 with polycythemia vera (PV) and 146 with essential thrombocythemia (ET). Multivariable Cox proportional hazards regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Smoking was not associated with MPN risk in the overall cohort, but analyses stratified by sex suggested that smoking increased the risk of MPN in women (former smoker vs. nonsmokers, HR = 1.43, 95% CI: 1.03-2.00, p = 0.03; current smokers vs. nonsmokers, HR = 1.71, 95% CI: 1.08-2.71, p = 0.02). Coffee consumption was inversely associated with the risk of PV (high vs. low intake, HR = 0.53, 95% CI: 0.33-0.84, p-trend < 0.01), but not the risk of ET or MPN overall. Further analysis revealed an inverse association between the amount of caffeine intake and PV risk (high vs. low intake, HR = 0.55, 95% CI: 0.39-0.79, p-trend < 0.01). While the consumption of caffeinated coffee appeared to confer a protective effect against PV, the consumption of decaffeinated coffee did not. This large prospective study identified smoking as a risk factor for MPN in women and suggests that caffeine intake is associated with a lower risk of PV.
© 2020 UICC.

Entities:  

Keywords:  epidemiology; lifestyle factors; myeloproliferative neoplasms

Mesh:

Year:  2020        PMID: 31904114      PMCID: PMC8919268          DOI: 10.1002/ijc.32853

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  40 in total

1.  Carcinogenicity of drinking coffee, mate, and very hot beverages.

Authors:  Dana Loomis; Kathryn Z Guyton; Yann Grosse; Béatrice Lauby-Secretan; Fatiha El Ghissassi; Véronique Bouvard; Lamia Benbrahim-Tallaa; Neela Guha; Heidi Mattock; Kurt Straif
Journal:  Lancet Oncol       Date:  2016-06-15       Impact factor: 41.316

2.  Molecular effects of taxol and caffeine on pancreatic cancer cells.

Authors:  B Gururajanna; A A Al-Katib; Y W Li; O Aranha; V K Vaitkevicius; F H Sarkar
Journal:  Int J Mol Med       Date:  1999-11       Impact factor: 4.101

3.  Food sources and intakes of caffeine in the diets of persons in the United States.

Authors:  Carol D Frary; Rachel K Johnson; Min Qi Wang
Journal:  J Am Diet Assoc       Date:  2005-01

4.  Prospective study of breast cancer in relation to coffee, tea and caffeine in Sweden.

Authors:  Jin-Kyoung Oh; Sven Sandin; Peter Ström; Marie Löf; Hans-Olov Adami; Elisabete Weiderpass
Journal:  Int J Cancer       Date:  2015-04-30       Impact factor: 7.396

5.  Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study.

Authors:  Ayalew Tefferi; Rakhee Vaidya; Domenica Caramazza; Christy Finke; Terra Lasho; Animesh Pardanani
Journal:  J Clin Oncol       Date:  2011-02-07       Impact factor: 44.544

Review 6.  Coffee and caffeine intake and breast cancer risk: an updated dose-response meta-analysis of 37 published studies.

Authors:  Wenjie Jiang; Yili Wu; Xiubo Jiang
Journal:  Gynecol Oncol       Date:  2013-03-25       Impact factor: 5.482

7.  Cytokine profiles in polycythemia vera and essential thrombocythemia patients: clinical implications.

Authors:  Emmanuel Pourcelot; Candice Trocme; Julie Mondet; Sébastien Bailly; Bertrand Toussaint; Pascal Mossuz
Journal:  Exp Hematol       Date:  2014-01-23       Impact factor: 3.084

8.  Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients.

Authors:  Francesco Passamonti; Elisa Rumi; Luca Arcaini; Emanuela Boveri; Chiara Elena; Daniela Pietra; Sabrina Boggi; Cesare Astori; Paolo Bernasconi; Marzia Varettoni; Ercole Brusamolino; Cristiana Pascutto; Mario Lazzarino
Journal:  Haematologica       Date:  2008-09-11       Impact factor: 9.941

9.  Caffeine induces apoptosis in human neuroblastoma cell line SK-N-MC.

Authors:  Mi-Hyeon Jang; Min-Chul Shin; In-Sug Kang; Hyung-Hwan Baik; Yong-Ho Cho; Jong-Phill Chu; Ee-Hwa Kim; Chang-Ju Kim
Journal:  J Korean Med Sci       Date:  2002-10       Impact factor: 2.153

Review 10.  Inflammation as a Driver of Clonal Evolution in Myeloproliferative Neoplasm.

Authors:  Angela G Fleischman
Journal:  Mediators Inflamm       Date:  2015-10-11       Impact factor: 4.711

View more
  6 in total

1.  Reply to comments on: Lifestyles and myeloproliferative neoplasms with special reference to coffee consumption.

Authors:  Nikolai A Podoltsev; Xiaoyi Wang; Rong Wang; Jonathan N Hofmann; Linda M Liao; Amer M Zeidan; Ruben Mesa; Xiaomei Ma
Journal:  Int J Cancer       Date:  2020-03-30       Impact factor: 7.396

2.  The Epidemiology of Myeloproliferative Neoplasms in New Zealand between 2010 and 2017: Insights from the New Zealand Cancer Registry.

Authors:  Chris Varghese; Tracey Immanuel; Anna Ruskova; Edward Theakston; Maggie L Kalev-Zylinska
Journal:  Curr Oncol       Date:  2021-04-18       Impact factor: 3.677

3.  Environmental Factors, Lifestyle Risk Factors, and Host Characteristics Associated With Philadelphia Negative Myeloproliferative Neoplasm: A Systematic Review.

Authors:  Niloofar Allahverdi; Mohamed Yassin; Mohamed Ibrahim
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

Review 4.  Insights into the Potential Mechanisms of JAK2V617F Somatic Mutation Contributing Distinct Phenotypes in Myeloproliferative Neoplasms.

Authors:  Panhong Gou; Wenchao Zhang; Stephane Giraudier
Journal:  Int J Mol Sci       Date:  2022-01-18       Impact factor: 5.923

5.  Diet and Risk of Myeloproliferative Neoplasms in Older Individuals from the NIH-AARP Cohort.

Authors:  Nikolai A Podoltsev; Xiaoyi Wang; Rong Wang; Jonathan N Hofmann; Linda M Liao; Amer M Zeidan; Ruben A Mesa; Xiaomei Ma
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-08-31       Impact factor: 4.254

Review 6.  Impact of Host, Lifestyle and Environmental Factors in the Pathogenesis of MPN.

Authors:  Gajalakshmi Ramanathan; Brianna M Hoover; Angela G Fleischman
Journal:  Cancers (Basel)       Date:  2020-07-24       Impact factor: 6.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.